A new COST Action No. CA23156 “European Network for Sigma-1 Receptor as a Therapeutic Opportunity (SIGMA-1EUROPE)” was launched on October 25, 2024. The SIGMA-1 EUROPE network will bring together disciplines and expertise across Europe to advance the exploration and identification of the role of Sigma-1 receptor in physiology and pathologies, to design innovative ligands and train young researchers. The Management Committee from Estonia is represented by Dr. Edijs Vavers and Prof. Allen Kaasik. Dr. Edijs Vavers was confirmed as the lead of WG5 and will be responsible for the Dissemination, Communication and Outreach of the network activities.
Comments are closed.
|